Maxwell Biotech VC fund finances fight against bronchial asthma

Marchmont News 21 September 2012 Maxwell Biotech, a Russian VC fund, has decided to invest in Eleventa, a start-up established earlier this year to develop and commercialize drugs to treat bronchial asthma and some other respiratory allergic diseases, the official...

RVC USA “melds US innovation with the resources of Russia”

From: East-West Digital News, Feb 02, 2012 Russian Venture Company (RVC), the state-owned fund of funds dedicated to innovation, is looking to invest in US startups through a newly-established office in Boston. RVC-USA presents itself as a “visionary and strategic...